【摘要】 目的探讨波立维联合脑心通治疗非ST段抬高型心肌梗死(NSTEMI)的临床效果。方法将60例NSTEMI患者按随机数字表法分为观察组和对照组,对照组30例给予常规综合治疗措施,观察组30例在常规综合治疗基础上同时给予波立维联合脑心通治疗,评估两者治疗效果。结果治疗后观察组患者CK、CK-MB及cTnT水平均低于对照组(P<0.05)。观察组显效率、总有效率明显高于对照组,2组比较差异有统计学意义(P<0.05)。结论波立维联合脑心通治疗非ST段抬高型心肌梗死的临床效果明确,值得应用。更多还原

【Abstract】 Objective To investigate the effect of Plavix combined with Naoxintongon on non-ST-elevation myocardial infarction(NSTEMI).Methods Sixty patients with NSTEMI were randomly treated with conventional therapy alone(control group,n=30)or in combination with Plavix and Naoxintong(observation group,n=30).Therapeutic efficacy was compared between the two groups.Results Compared with control group,the combined treatment with Plavix and Naoxintong significantly decreased the levels of creatinine kinase,creatine kinase-MB and cardiac troponin T,but obviously increased significant effective rate and total effective rate(P<0.05).Conclusion The combined treatm-ent with Plavix and Naoxintong is effective and worthy of application in NSTEMI.更多还原